Neuropsychiatric Disease and Treatment
Volume 19, 2023 - Issue
ORIGINAL RESEARCH
Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM
Robert Litman1 CBH Health LLC, Gaithersburg, MD, USA;2 Department of Psychiatry, Georgetown University Medical School, Washington, DC, USA
https://orcid.org/0000-0002-8324-9658View further author information
https://orcid.org/0000-0002-8324-9658View further author information, , Lourdes Anta4 Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, Spainhttps://orcid.org/0000-0001-5981-1850View further author information
https://orcid.org/0000-0001-5981-1850View further author information, Javier Martínez4 Medical Department, Laboratorios Farmacéuticos ROVI, S.A., Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0001-6314-4480View further author information
https://orcid.org/0000-0001-6314-4480View further author information, Yuriy Filts5 Communal Noncommercial Enterprise of Lviv Regional Council, Lviv Regional Clinical Psychiatric Hospital, Lviv, Ukrainehttps://orcid.org/0000-0001-8158-4332View further author information
https://orcid.org/0000-0001-8158-4332View further author information & Christoph U Correll6 Department of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, NY, USA;7 Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA;8 Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germanyhttps://orcid.org/0000-0002-7254-5646View further author information
https://orcid.org/0000-0002-7254-5646View further author information